跳至主要内容
临床试验/NCT02088970
NCT02088970终止不适用

Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study.

Nantes University Hospital1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
21
试验地点
1
主要终点
Duration of corneal complete epithelial healing in days.

研究概览

简要总结

The corneal collagen cross linking is currently used in the treatment of keratoconus but this procedure has also a sterilizing non-specific effect on bacteria and fungus. So the corneal cross linking in association with the antibiotic treatment could result in a reduction of the duration of epithelial complete healing of the cornea.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Infectious bacterial or fungal keratitis with : size > 2mm or within the central corneal area ( 3mm of the visual axis ) or with a reaction in anterior chamber.
  • Being major responsible.
  • Agreement in writing to participate in the study.
  • Being affiliated to a national insurance scheme.

排除标准

  • Present an infectious keratitis without all the previous criteria.
  • Herpes or acanthamoeba keratitis
  • preperforated or perforated cornea.
  • General criteria:
  • Pregnant woman.
  • Minors(miners).
  • Adults under guardianship.
  • Patient can not be followed during 3 necessary months.
  • French speaking patient.
  • Unaffiliated patient in a national insurance scheme.
  • HIV infected patients

研究组 & 干预措施

antibiotic treatment alone

Active Comparator

干预措施: antibiotic treatment (Drug)

Crosslinking + Antibiotic

Experimental

The procedure of the cross linking is standard:combined riboflavin(Ricrolin®)-ultraviolet type A rays (UVA) collagen cross-linking. Radiant energy was 3 milliwatts/cm2 or 5.4 joule/cm2 for a 30-minute exposure irradiation of the cornea.

Patients are checked every days during the hospitalisation and one week, one month and 3 months after the hospitalisation.

干预措施: Crosslinking (Device)

Crosslinking + Antibiotic

Experimental

The procedure of the cross linking is standard:combined riboflavin(Ricrolin®)-ultraviolet type A rays (UVA) collagen cross-linking. Radiant energy was 3 milliwatts/cm2 or 5.4 joule/cm2 for a 30-minute exposure irradiation of the cornea.

Patients are checked every days during the hospitalisation and one week, one month and 3 months after the hospitalisation.

干预措施: antibiotic treatment (Drug)

结局指标

主要结局

Duration of corneal complete epithelial healing in days.

时间窗: 3 months

次要结局

  • Gain of visual acuity(3 months)
  • Size of the corneal scar(3months)
  • Corneal thinning(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验